Saturday, August 15, 2026

THE DEAL Is Done! Canada Just AXED Its Closest Ally To Buy Korean Subs—Is This The End of The US-Canada Defense Pact?

South Korea and Canada discuss enhancing defense cooperation, including a submarine program, to strengthen bilateral relations.

Honda Puts Major Canada EV Project on Hold and Shifts Focus to Hybrids

Honda has postponed its EV factory plans in Canada due to declining U.S. demand, scaling back investments and focusing on hybrids.

Iran Football Team’s Travel Restrictions Eased Ahead of FIFA World Cup 2026: What You Need to Know

The U.S. eases travel restrictions for Iran's soccer team ahead of their FIFA World Cup match, allowing earlier entry into the country.

Tag: ST Pharm

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm showcased its CDMO capabilities at TIDES USA and ASGCT 2026, focusing on nucleic acid therapeutics and strategic partnerships.

ST Pharm Secures Key mRNA-LNP Patent STP1244 in Japan

ST Pharm secures a patent in Japan for its mRNA delivery technology, enhancing its global market position and IP portfolio.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.